Marin Biologic Laboratories celebrates passing FDA inspection and service expansion. Discover how we're enhancing biopharmaceutical research
Marin Biologic Laboratories, a leading contract research organization in the field of biological and biopharmaceutical development, proudly announces the successful completion of a U.S. Food and Drug Administration (FDA) inspection for commercial drugs at its state-of-the-art facility in Novato, California. The rigorous inspection confirms Marin Biologic Laboratories’ compliance with Current Good Manufacturing Practices (cGMP). The rigor of cGMP for commercial drugs is significantly greater than that for early clinical phase pharmaceuticals.















